Anthony Christopher Vernon
Affiliations: | King's College (London), London, England, United Kingdom |
Area:
Neuroscience, schizophrenia, parkinson's diseaseGoogle:
"Anthony Vernon"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| David T. Dexter | grad student | 2002-2007 | Imperial College & Sheffield University |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hanger B, Couch A, Rajendran L, et al. (2020) Emerging Developments in Human Induced Pluripotent Stem Cell-Derived Microglia: Implications for Modelling Psychiatric Disorders With a Neurodevelopmental Origin. Frontiers in Psychiatry. 11: 789 |
| Andersen HG, Raghava JM, Svarer C, et al. (2020) Striatal Volume Increase After Six Weeks of Selective Dopamine D Receptor Blockade in First-Episode, Antipsychotic-Naïve Schizophrenia Patients. Frontiers in Neuroscience. 14: 484 |
| Onwordi EC, Halff EF, Whitehurst T, et al. (2020) Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats. Nature Communications. 11: 246 |
| Fletcher EJR, Finlay CJ, Amor Lopez A, et al. (2020) Neuroanatomical and Microglial Alterations in the Striatum of Levodopa-Treated, Dyskinetic Hemi-Parkinsonian Rats Frontiers in Neuroscience. 14 |
| Peris-Yague A, Kiemes A, Cash D, et al. (2020) T209. EFFECTS OF CHRONIC HALOPERIDOL EXPOSURE ON [3H]RO15-4513 AND [3H]FLUMAZENIL GABA-A RECEPTOR BINDING SITES Schizophrenia Bulletin. 46: S312-S312 |
| Chika Onwordi E, Halff E, Whitehurst T, et al. (2020) O11.3. SYNAPTIC MARKER PROTEIN SV2A IS REDUCED IN SCHIZOPHRENIA IN VIVO AND UNAFFECTED BY ANTIPSYCHOTICS IN RATS Schizophrenia Bulletin. 46: S28-S28 |
| Kuan WL, Stott K, He X, et al. (2019) Systemic α-synuclein injection triggers selective neuronal pathology as seen in patients with Parkinson's disease. Molecular Psychiatry |
| Turkheimer FE, Selvaggi P, Mehta MA, et al. (2019) Normalizing the Abnormal: Do Antipsychotic Drugs Push the Cortex Into an Unsustainable Metabolic Envelope? Schizophrenia Bulletin |
| Doostdar N, Kim E, Grayson B, et al. (2019) Global brain volume reductions in a sub-chronic phencyclidine animal model for schizophrenia and their relationship to recognition memory. Journal of Psychopharmacology (Oxford, England). 269881119844196 |
| Cotel M, Lindenmaier Z, Lenartowicz E, et al. (2019) 179. Effects of Chronic Haloperidol Treatment on Brain Volume in a Rat Model in of Infection-Mediated Neurodevelopmental Disorders Biological Psychiatry. 85: S74 |